Keynote Speakers 2022

Keynote Speakers

Andrew Vickers, PhD, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center

Dr. Vickers' research falls into three broad areas: randomized trials, outcomes research and molecular marker studies. A particular focus of his work is the detection and initial treatment of prostate cancer. Dr Vickers developed a statistical model to predict the result of prostate biopsy, work that has led to commercial test that is clinically avalaible through Opko Diagnostics. In other research, he has established the strong predictive value of mid-life prostate specific antigen (PSA) for long-term prostate cancer mortality, shown that PSA velocity is not of benefit for risk prediction in localized disease, conducted modelling studies questioning the aggressiveness of cancers Foundation by image-guided targeting and demonstrated that genetic risk prediction should focus on the endpoint of cancer morbidity and mortality Ect. 


Keynote Speakers

Anssi Auvinen, Director of the Prostate Cancer Research Center, Professor of epidemiology at Tampere University

Anssi Auvinen has a medical background and has worker in the field of cancer epidemiology for there decades. His main affiliation is professor of epidemiology at Tampere University, where he is also the director of the Prostate Cancer Reseach Center. He has also worked for as a visiting professor at Erasmus University Rotterdam, International Agency for Research on Cancer and Finnish Cancer Institute, as well as a opsat-doc at the U.S. National Cancer Institute. He has been the PI of the Finnish randomised Study of Screening for Prostate Cancer (FinRSPC) and co-coordinator of the European Randomised Study of Prostate Cancer screening (ERSPC). Ect. 


Keynote Speakers

Joachim Wiskemann, PhD, National Center for Tumor Diseases, University Heidelberg

Joachim Wiskemann has substantial experience in planning and tailoring exercise programs to cancer patients needs and capabilities and conducted exercise studies in cancer patients for more than 15 years. Dr Wiskemann published more than 100 papers in the field including several landmark studies and provided new infights into exercise oncology in a variety of cancer enities. Based on his Scientific discoveries, Joachim Wiskemann started early serving the closer and sider Heidelberg cancer community by developing an unique exercise program for cancer patients offering more than 50 hours of exercise therapy/counselling a week at the National Center for Tumor Diseases in Heidelberg (2010). 


Keynote Speakers

Karen Freund, Tufts Medical Center and Tufts University School of Medicine

Trained as a primary care physician who continues to see her own patients. Dr. Freund has broad understanding of the clinical issues in cancer prevention, care, and survivorship. Her research focuses on cancer prevention and control, and addressing cancer health disparities. She serves as one of the lead investigators of a grant funded by the US. National Institutes of Health, entitled "Translating Research into Practise". This project is a pragmatic clinical trial, investigating the impact of implementing a standardized program of patient navigation across the city of Boston to reduce racial/ethnic and economic disparities in breast cancer outcomes. The trial includes eligible patients at six hospitals in the Boston area, each adapting their practise to a new standard of care.


Keynote Speakers

Lonneke van de Poll-Franse, Professor of Cancer Epidemiology and Survivorship at the Netherlands Cancer Institute (NCI), Tilburg University

Her research focuses on identifying and understanding the physical and psychological concequences of cancer and treatment. In 2009 she set up the Patient Reported Outcomes Following Initial treatment and Long-term Evaluation of Survivorship (PROFILES) registre, which combines population data from the Netherlands Cancer Registry with patient-reported outcomes as well as information on nutrition and physical activity measured with apps and wearables. At the NCI, Professor van de Poll leads the survivorship research program. 


Keynote Speakers

Ismail Gögenur, Professor, DMSc, Consultant, Department of Surgery, Zealand University Hospital

Ismail Gögenur is the founder and leader of Center for Surgical Science, a multidisiplinary research unit involved in translational research, clinical research and Big Data methodologies. His research focus is within the developement and implementation of new surgical treatments along with surgical pathophysiology. In 2020, he established a `patient near` translational research labatory at Zealand University Hospital with the aim of utilizing patient database and biobanks to predict treatment outcomes in-vitro and integrating these research outcomes in clinical trials to create an accelerated "bench to bedside" framework. Ismail Gögenur acts as chairman of the Scientific Committee in Danish Colorectal Cancer Group, and is a member of several national and international research groups performing studies within surgical oncology, along with being a member of the implementation council for Personalized Medicine for Eastern Denmark.


Keynote Speakers

Marianne Nord Hansen, nurse, sociologist, and chairman of the Danish Association for Late Effects after Cancer

Marianne Nord Hansen, nurse and sociologist has been the chairman of the Danish Association for Late Effects after Cancer since 2008. Her research focuses on quality developement and documentation in the health care system. As a volunteer she speaks daily to cancer patients and cancer survivors, and help them to get assesment and treatment for their late effects. She is involved in the specialist training for oncology nurses, e.g. by seminars, networking, publications, hotline telephone. Marianne Nord Hansen is a member of the Steering Committee for The Danish Cancer Society, and seated in councils advising The Danish Health Authority.


Keynote Speakers

Charlotte Hammar, MA, Vice Chariman of the Danish Association for Late Effects after Cancer

Charlotte Hammar is in charge of multiple tasks in The Danish Association for Late Effects after Cancer, including strategic developement of the organization, political lobbying, writing articles, responsible for PR, volunteers, member activities and secretariat.